Filing Details

Accession Number:
0001062993-23-011545
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-18 14:12:44
Reporting Period:
2023-05-17
Accepted Time:
2023-05-18 14:12:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1374690 Larimar Therapeutics Inc. LRMR Pharmaceutical Preparations (2834) 203857670
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1452429 Joseph Truitt C/O Larimar Therapeutics, Inc.
Three Bala Plaza East, Suite 506
Bala Cynwyd PA 19004
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-17 2,750 $3.73 2,750 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct